Quang X. Pham

All filings by Quang X. Pham on record concern Cadrenal Therapeutics, Inc. Between 10 February 2023 and 29 June 2026, the trades on record add up to 34 filings.

Market trades split into 2 purchases (€26k) and 29 sales (€238k). The amount is not disclosed for 13 filings. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 1 share grant. In 2026 alone, the filings show no purchases and 22 sales.

On 1 July 2026 came the latest disclosure, an open-market sale in Cadrenal Therapeutics, Inc. The last insider purchase was made public on 6 September 2023, 1,138 days ago. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.